Bristol-Myers Squibb Company (BIT:1BMY)

Italy flag Italy · Delayed Price · Currency is EUR
38.80
-0.20 (-0.53%)
At close: Oct 3, 2025
-0.53%
Market Cap76.98B
Revenue (ttm)40.62B
Net Income (ttm)4.30B
Shares Outn/a
EPS (ttm)2.12
PE Ratio17.91
Forward PE6.85
Dividend2.22 (5.73%)
Ex-Dividend DateOct 2, 2025
Volume180
Average Volume231
Open38.64
Previous Close39.00
Day's Range38.56 - 38.80
52-Week Range37.21 - 57.80
Betan/a
RSI42.34
Earnings DateOct 30, 2025

About BIT:1BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Borsa Italiana
Ticker Symbol 1BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.